As of 2025-03-19, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (18.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.44 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -527.3%.
The range of the Relative Valuation is (18.23) - (24.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 16.5x | 14.1x |
| Forward P/E multiples | 5.1x - 15.4x | 10.2x |
| Fair Price | (18.23) - (24.00) | (18.97) |
| Upside | -510.6% - -640.5% | -527.3% |
| Date | P/E |
| 2025-03-18 | -2.89 |
| 2025-03-17 | -2.96 |
| 2025-03-14 | -2.84 |
| 2025-03-13 | -2.90 |
| 2025-03-12 | -2.96 |
| 2025-03-11 | -2.82 |
| 2025-03-10 | -2.83 |
| 2025-03-07 | -2.90 |
| 2025-03-06 | -2.89 |
| 2025-03-05 | -2.97 |
| 2025-03-04 | -2.75 |
| 2025-03-03 | -2.78 |
| 2025-02-28 | -3.06 |
| 2025-02-27 | -3.09 |
| 2025-02-26 | -3.21 |
| 2025-02-25 | -3.30 |
| 2025-02-24 | -3.31 |
| 2025-02-21 | -3.37 |
| 2025-02-20 | -3.56 |
| 2025-02-19 | -3.77 |
| 2025-02-18 | -3.79 |
| 2025-02-14 | -3.95 |
| 2025-02-13 | -3.99 |
| 2025-02-12 | -3.54 |
| 2025-02-11 | -3.48 |
| 2025-02-10 | -3.41 |
| 2025-02-07 | -2.89 |
| 2025-02-06 | -2.64 |
| 2025-02-05 | -2.82 |
| 2025-02-04 | -2.63 |
| 2025-02-03 | -2.56 |
| 2025-01-31 | -2.68 |
| 2025-01-30 | -2.79 |
| 2025-01-29 | -2.55 |
| 2025-01-28 | -2.63 |
| 2025-01-27 | -2.64 |
| 2025-01-24 | -2.56 |
| 2025-01-23 | -2.81 |
| 2025-01-22 | -2.80 |
| 2025-01-21 | -2.83 |
| 2025-01-17 | -2.75 |
| 2025-01-16 | -2.77 |
| 2025-01-15 | -2.79 |
| 2025-01-14 | -2.69 |
| 2025-01-13 | -2.77 |
| 2025-01-10 | -2.73 |
| 2025-01-08 | -3.00 |
| 2025-01-07 | -2.98 |
| 2025-01-06 | -2.99 |
| 2025-01-03 | -3.08 |